Jci_page_head_homepage_01 Jci_page_head_homepage_02
James B. Dale, Edna Y. Chiang, Shaoyou Liu, Harry S. Courtney, David L. Hasty
Published in Volume 103, Issue 9
J Clin Invest. 1999; 103(9):1261 doi:10.1172/JCI5118
Abstract | Full text | PDF
Citation information

Total citations by year in CrossRef

Year: 2011 2009 2008 2006 2005 2004 2003 2001 Total
Citations: 1 3 1 4 3 2 3 3 20

Citations to this article in CrossRef (20)

Title and authors Publication Year
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci
James B. Dale, Thomas A. Penfound, Edna Y. Chiang, William J. Walton
Vaccine 2011
Vaccines under study: non-HIV vaccines
Kelly Conner, Alice Wuu, Victoria Maldonado, Brenda L. Bartlett, Stephen K. Tyring
Dermatologic Therapy 2009
Streptococcal protective antigens (Spa): a new family of type-specific proteins of group A streptococci
E. A. Ahmed, T. A. Penfound, S. C. Brewer, P. A. Tennant, E. Y. Chiang, J. B. Dale
Eur J Clin Microbiol Infect Dis 2009
Localization of the equine IgG-binding domain in the fibrinogen-binding protein (FgBP) of Streptococcus equi subsp. equi
M. Meehan, M. J. Lewis, C. Byrne, D. O'Hare, J. M. Woof, P. Owen
Microbiology 2009
Human pathogenic streptococcal proteomics and vaccine development
Jason N. Cole, Anna Henningham, Christine M. Gillen, Vidiya Ramachandran, Mark J. Walker
Prot. Clin. Appl. 2008
Anti-phagocytic mechanisms of Streptococcus pyogenes: binding of fibrinogen to M-related protein
Harry S. Courtney, David L. Hasty, James B. Dale
Mol Microbiol 2006
Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome
Manuel J Rodríguez-Ortega, Nathalie Norais, Giuliano Bensi, Sabrina Liberatori, Sabrina Capo, Marirosa Mora, Maria Scarselli, Francesco Doro, Germano Ferrari, Ignazio Garaguso, Tiziana Maggi, Anita Neumann, Alessia Covre, John L Telford, Guido Grandi
Nat Biotechnol 2006
Domains of group A streptococcal M protein that confer resistance to phagocytosis, opsonization and protection: implications for vaccine development
Jason D. McArthur, Mark J. Walker
Mol Microbiol 2006
A double-blind, randomized phase II trial of the safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults
Shelly A. McNeil, Scott A. Halperin, Joanne M. Langley, Bruce Smith, Darlene M. Baxendale, Andrew Warren, Geoffrey P. Sharratt, Mark A. Reddish, Louis F. Fries, Peter E. Vink, James B. Dale
International Congress Series 2006
Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers
S. A. McNeil, S. A. Halperin, J. M. Langley, B. Smith, A. Warren, G. P. Sharratt, D. M. Baxendale, M. A. Reddish, M. C. Hu, S. D. Stroop, J. Linden, L. F. Fries, P. E. Vink, J. B. Dale
CLIN INFECT DIS 2005